Risklick

Switzerland
Bulle, Fribourg, Switzerland, 3013

Company profile

Risklick company profile

Risklick is develops a first-of-the-kind data-driven tool to allow end-users to identify similar Clinical trials(CTs) and assess risks in early steps of the protocol design. CTs are used to determine the efficacy and safety of an experimental treatment; however, up to 90% of them fail in the early stage of protocol design and the nature and complexity of CTs make risk assessment difficult and time-consuming.

Business identity

Contact email
[email protected]
Phone number
+41 78 781 41 35
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Founded
2019-01-01, Year

Headquarters

Postal code
3013
Country code
CH
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
1
Last funding
Seed / 2024-04-23
Last equity funding
Seed
Investors
1
Lead investors
1
Founders
1
Articles
9

Founders and investors

Founders

Cedric Odje

Lead investors

Debiopharm Innovation Fund

Investors

Debiopharm Innovation Fund